Integra Lifesciences Holdings Corp
IART- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000917520
No open-market purchases or sales by Integra Lifesciences Holdings Corp insiders were filed in the last 90 days; 212 institutions reported holding it in 13F filings for Q2 2026, worth $1.32B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Integra Lifesciences Holdings Corp as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 281
- +4 vs. Q3 2022
- Shares held
- 75.0M
- +6.33M (+9.2%) vs. Q3 2022
- Total value
- $4.20B
- +$1.29B (+44.2%) vs. Q3 2022
- New holders
- 42
- 93 more added
- Sold out
- 38
- 98 more reduced
5 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IART on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 212 | $1.32B |
| Q1 2026 | 202 | $704.7M |
| Q4 2025 | 205 | $919.4M |
| Q3 2025 | 207 | $1.04B |
| Q2 2025 | 209 | $896.9M |
| Q1 2025 | 220 | $1.62B |
| Q4 2024 | 223 | $1.57B |
| Q3 2024 | 225 | $1.24B |
| Q2 2024 | 238 | $2.07B |
| Q1 2024 | 281 | $2.34B |
| Q4 2023 | 284 | $2.92B |
| Q3 2023 | 263 | $2.63B |
| Q2 2023 | 283 | $2.85B |
| Q1 2023 | 280 | $4.18B |
| Q4 2022 | 281 | $4.20B |
| Q3 2022 | 282 | $3.13B |
| Q2 2022 | 285 | $3.95B |
| Q1 2022 | 278 | $4.80B |
| Q4 2021 | 277 | $5.19B |
| Q3 2021 | 262 | $5.27B |
| Q2 2021 | 264 | $5.10B |
| Q1 2021 | 257 | $5.10B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Integra Lifesciences Holdings Corp; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −11,500−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −11,367−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −10,770−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −9,971−100.0% | Sold out |
| MQS Management LLC | 0 | $0 | 0.00% | −8,192−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −8,184−100.0% | Sold out |
| Teza Capital Management LLC | 0 | $0 | 0.00% | −8,114−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −6,561−100.0% | Sold out |
| Hantz Financial Services, Inc. | 0 | $0 | 0.00% | −5,626−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −5,557−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −4,734−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −1,438−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −716−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −668−100.0% | Sold out |
| Riverview Trust Co | 0 | $0 | 0.00% | −279−100.0% | Sold out |
| Capital Analysts, LLC | 0 | $0 | 0.00% | −192−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −146−100.0% | Sold out |
| Howe & Rusling Inc | 0 | $0 | 0.00% | −86−100.0% | Sold out |
| MUFG Americas Holdings Corp | 0 | $0 | 0.00% | −62−100.0% | Sold out |
| Eaton Vance Management | – | – | – | – | Not filed |
| Atlanta Capital Management Co L L C | – | – | – | – | Not filed |
| Jefferies Group LLC | – | – | – | – | Not filed |
| Wipfli Financial Advisors LLC, | – | – | – | – | Not filed |
| FourThought Financial, LLC | – | – | – | – | Not filed |